Paper39201722
The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature.
Chang KJ and 2 others. Int J Mol Sci, 2024. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature. Papers, record 39201722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201722
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Pathophysiological Mechanism and Clinical Treatment of Polycystic Ovary Syndrome: A Molecular and Cellular Review of the Literature.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Polycystic Ovary Syndrome | Major topic |
| Insulin Resistance | Major topic |
| Humans | |
| Female | |
| Signal Transduction | |
| Animals |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TCRD-TPE-113-12 | Taipei Tzu Chi Hospital | PubMed |
Source PubMed
References106
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27559705 | Polycystic ovary syndrome and environmental toxins. | Fertil Steril | 2016 | https://conductscience.org/library/papers/27559705 | PubMed |
| 2 | 31920361 | Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives. | Appl Clin Genet | 2019 | https://conductscience.org/library/papers/31920361 | PubMed |
| 3 | 33518179 | Diagnosis of Polycystic Ovary Syndrome: Which Criteria to Use and When? | Endocrinol Metab Clin North Am | 2021 | https://conductscience.org/library/papers/33518179 | PubMed |
| 4 | 30463276 | Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity. | Int J Environ Res Public Health | 2018 | https://conductscience.org/library/papers/30463276 | PubMed |
| 5 | 35299965 | The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35299965 | PubMed |
| 6 | 29386951 | Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits. | Open Access J Contracept | 2017 | https://conductscience.org/library/papers/29386951 | PubMed |
| 7 | 32701517 | Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome. | Clin Obstet Gynecol | 2021 | https://conductscience.org/library/papers/32701517 | PubMed |
| 8 | 34127827 | Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies. | Genes Immun | 2021 | https://conductscience.org/library/papers/34127827 | PubMed |
| 9 | 35882755 | Effects of Bariatric Surgery on People with Obesity and Polycystic Ovary Syndrome: a Large Single Center Study from India. | Obes Surg | 2022 | https://conductscience.org/library/papers/35882755 | PubMed |
| 10 | 33278735 | The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes. | Curr Opin Pharmacol | 2020 | https://conductscience.org/library/papers/33278735 | PubMed |
| 11 | 15583024 | Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. | Endocr Rev | 2004 | https://conductscience.org/library/papers/15583024 | PubMed |
| 12 | 9147642 | Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. | Hum Mol Genet | 1997 | https://conductscience.org/library/papers/9147642 | PubMed |
| 13 | 34274528 | Insulin action at a molecular level - 100 years of progress. | Mol Metab | 2021 | https://conductscience.org/library/papers/34274528 | PubMed |
| 14 | 32000752 | Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome. | BMC Endocr Disord | 2020 | https://conductscience.org/library/papers/32000752 | PubMed |
| 15 | 18950759 | The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. | Fertil Steril | 2009 | https://conductscience.org/library/papers/18950759 | PubMed |
| 16 | 36243120 | Letrozole: Pharmacology, toxicity and potential therapeutic effects. | Life Sci | 2022 | https://conductscience.org/library/papers/36243120 | PubMed |
| 17 | 36105409 | Assessment of prevalence, knowledge of polycystic ovary syndrome and health-related practices among women in klang valley: A cross-sectional survey. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36105409 | PubMed |
| 18 | 30067154 | Mechanisms of Insulin Action and Insulin Resistance. | Physiol Rev | 2018 | https://conductscience.org/library/papers/30067154 | PubMed |
| 19 | 29569621 | Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. | Nat Rev Endocrinol | 2018 | https://conductscience.org/library/papers/29569621 | PubMed |
| 20 | 31603907 | Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. | PLoS One | 2019 | https://conductscience.org/library/papers/31603907 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42968959 | Mechanism Analysis of Chronic Inflammation in Polycystic Ovary Syndrome and Targeted Therapeutic Strategies Based on Bioactive Constituents of Traditional Chinese Medicine. | Int J Womens Health | 2026 | https://conductscience.org/library/papers/42968959 | PubMed |
| 42900350 | Roles and Biological Effects of Polysaccharides in Polycystic Ovary Syndrome: A Narrative Review. | Reprod Sci | 2026 | https://conductscience.org/library/papers/42900350 | PubMed |
| 42884669 | Nutritional Management of Polyendocrine Metabolic Ovarian Syndrome: Current Evidence on Dietary Strategies, Supplementation, and Lifestyle Support. | Nutrients | 2026 | https://conductscience.org/library/papers/42884669 | PubMed |
| 42781628 | The diagnostic value of serum 25-hydroxyvitamin D, MIS, and insulin-like growth factor 1 for polycystic ovary syndrome (PCOS). | J Med Biochem | 2026 | https://conductscience.org/library/papers/42781628 | PubMed |
| 42761446 | Gypenosides ameliorate polycystic ovary syndrome via gut microbiota modulation: An integrated gut microbiome and ovarian transcriptome study. | iScience | 2026 | https://conductscience.org/library/papers/42761446 | PubMed |
| 42638986 | Physical activity, sedentary behavior, and metabolic-reproductive health in women with PMOS (PCOS): a narrative review of mechanisms, clinical evidence, and individualized intervention strategies. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42638986 | PubMed |
| 42491030 | Clinical efficacy of liraglutide combined with pioglitazone in obese polycystic ovary syndrome and its effects on the serum chemerin/visfatin ratio. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42491030 | PubMed |
| 42440101 | ZBP1-driven PANoptosis in granulosa cells mediates follicular arrest in PCOS: integrated transcriptomic evidence and baicalin's therapeutic potential. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42440101 | PubMed |
| 42417910 | Therapeutic potential of natural products in polycystic ovary syndrome. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42417910 | PubMed |
| 42404346 | Hydrogen sulfide donor sodium hydrosulfide modulates ovarian steroidogenesis and follicular integrity in a DHEA-induced rat model of polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42404346 | PubMed |
| 42387242 | Fucoxanthin Ameliorates Polycystic Ovary Syndrome by Coordinated Modulation of NF-κB and Nrf2 Signaling: Evidence from a DHEA-Induced Mouse Model. | Reprod Sci | 2026 | https://conductscience.org/library/papers/42387242 | PubMed |
| 42271514 | Efficacy and safety of SarogLItazar as an add-on medication to Metformin and lifestyle intervention in women with PolyCystic Ovary Syndrome (SLIM-PCOS trial): study protocol for a randomized, open-label, parallel group clinical trial. | Trials | 2026 | https://conductscience.org/library/papers/42271514 | PubMed |
| 42239729 | Vitamin D status tracks inflammation perfusion and pregnancy in polycystic ovary syndrome. | iScience | 2026 | https://conductscience.org/library/papers/42239729 | PubMed |
| 42193130 | Reduced CAG Repeats in the Androgen Receptor Gene May Independently Cause Polycystic Ovarian Syndrome. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42193130 | PubMed |
| 42157915 | Decoding the Methylome: Insights into the Epigenetic Regulation of Polycystic Ovarian Syndrome through Mitochondrial DNA Methylation. | Curr Genomics | 2025 | https://conductscience.org/library/papers/42157915 | PubMed |
| 42039130 | Effects of polycystic ovary syndrome on liver, heart, muscle, and pancreatic-related diseases. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42039130 | PubMed |
| 42010141 | Molecular Mechanisms Underlying Reproductive Dysfunction in Polycystic Ovary Syndrome. | Reprod Sci | 2026 | https://conductscience.org/library/papers/42010141 | PubMed |
| 41917318 | A Comprehensive Review on Recent Advancements in Navigating the Complexities of Polycystic Ovarian Syndrome (PCOS). | Reprod Sci | 2026 | https://conductscience.org/library/papers/41917318 | PubMed |
| 41900420 | Probiotic Modulation of the Gut-Ovary and Gut-Myometrium Axes: An In Vitro Study. | Microorganisms | 2026 | https://conductscience.org/library/papers/41900420 | PubMed |
| 41872939 | Oxidative stress and the therapeutic potential of dietary antioxidants in polycystic ovary syndrome: a narrative review. | J Ovarian Res | 2026 | https://conductscience.org/library/papers/41872939 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201722
GET https://conductscience.org/api/papers/v1/39201722/references?page=2